PEG-Intron

Pays: Nouvelle-Zélande

Langue: anglais

Source: Medsafe (Medicines Safety Authority)

Ingrédients actifs:

Peginterferon alfa-2b 150ug

Disponible depuis:

Schering-Plough a division of Schering-Plough Animal Health Limited

DCI (Dénomination commune internationale):

Peginterferon alfa-2b 150 µg

Dosage:

150 mcg

forme pharmaceutique:

Powder for injection

Composition:

Active: Peginterferon alfa-2b 150ug Excipient: Dibasic sodium phosphate Monobasic sodium phosphate dihydrate Polysorbate 80 Sucrose Water for injection

Unités en paquet:

Ampoule, Diluent, 2 mL

classe:

Prescription

Type d'ordonnance:

Prescription

Fabriqué par:

Schering-Plough Company

Descriptif du produit:

Package - Contents - Shelf Life: Ampoule, Diluent - 2 mL -   - Combination pack, 1 x (Powder + Diluent) - 150 ?g - 36 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze) - Combination pack, 2 x (Powder + Diluent) - 300 ?g - 36 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze) - Combination pack, 4 x (Powder + Diluent) - 600 ?g - 36 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze) - Vial, glass, 1 x 150?g - 150 ?g - 36 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze)

Date de l'autorisation:

1999-11-16